The New York Times @nytimes
The FDA has approved the first treatment that can delay — possibly for years — the onset of Type 1 diabetes, a disease that often emerges in teenagers. The 14-day treatment will cost nearly $200,000. https://t.co/ptTVWe1d20 — PolitiTweet.org